PedAM
Pediatric Disease Annotations & Medicines
| Disease | pulmonary hypertension |
| Phenotype | C0036421|systemic sclerosis |
| Sentences | 29 |
| PubMedID- 23559973 | The rationale for using tnf-α antagonists in systemic sclerosis associated with pulmonary hypertension arises from overproduction of this cytokine in the disease and contribution to lung interstitial and vascular damage23). |
| PubMedID- 24155365 | Iron deficiency in systemic sclerosis patients with and without pulmonary hypertension. |
| PubMedID- 23780636 | Prevalence of pulmonary hypertension in systemic sclerosis in european caucasians and metaanalysis of 5 studies. |
| PubMedID- 20598164 | As pulmonary hypertension in systemic sclerosis may not only be due to pah, but also to interstitial lung disease and cardiac involvement[6-9], it is very important to classify it adequately[10,11] in order to determine the best treatment. |
| PubMedID- 25036561 | Incidence of pulmonary hypertension in patients with systemic sclerosis and no pulmonary symptoms: is annual echocardiographic screening necessary. |
| PubMedID- 25104236 | Influence of pulmonary vascular reserve on exercise-induced pulmonary hypertension in patients with systemic sclerosis. |
| PubMedID- 19101049 | pulmonary hypertension in systemic sclerosis determines cardiac autonomic dysfunction assessed by heart rate turbulence. |
| PubMedID- 23042670 | Dyspnea assessment and pulmonary hypertension in patients with systemic sclerosis: utility of the university of california, san diego, shortness of breath questionnaire. |
| PubMedID- 20722025 | Exercise-induced pulmonary hypertension associated with systemic sclerosis: four distinct entities. |
| PubMedID- 20382500 | Conclusion: hrct-determined severity and extent of pulmonary fibrosis may be helpful in screening for pulmonary hypertension in patients with systemic sclerosis. |
| PubMedID- 20425528 | Diagnosis and management of pulmonary hypertension in systemic sclerosis. |
| PubMedID- 25705389 | Several groups have demonstrated that ild-associated pulmonary hypertension in systemic sclerosis is associated with a significantly poorer survival than systemic sclerosis-pah, despite similar pulmonary haemodynamics [26,61]. |
| PubMedID- 26489821 | Electrocardiographic detection of pulmonary hypertension in patients with systemic sclerosis using the ventricular gradient. |
| PubMedID- 25146407 | Objective: to study the clinical, cardiopulmonary functional and hemodynamic profiles of systemic sclerosis patients with pulmonary hypertension (ssc-pah) compared with those of idiopathic pulmonary hypertension (ipah). |
| PubMedID- 20526641 | Early detection of pulmonary hypertension (ph) in patients with systemic sclerosis (ssc) is essential as it leads to substantial morbidity and mortality irrespective of its etiology. |
| PubMedID- 23292818 | Epidemiology and risk factors for pulmonary hypertension in systemic sclerosis. |
| PubMedID- 23740875 | Submaximal heart and pulmonary evaluation: a novel noninvasive test to identify pulmonary hypertension in patients with systemic sclerosis. |
| PubMedID- 25284845 | Another report[134] mentions the efficacy of infliximab treatment in a patient with lung fibrosis and pulmonary hypertension associated with advanced systemic sclerosis, refractory to conventional therapies. |
| PubMedID- 21047671 | pulmonary hypertension in systemic sclerosis. |
| PubMedID- 23372926 | [fra-2 transgenic mice as a novel model of pulmonary hypertension associated with systemic sclerosis. |
| PubMedID- 22523431 | Fra-2 transgenic mice as a novel model of pulmonary hypertension associated with systemic sclerosis. |
| PubMedID- 23499807 | N-terminal pro-brain natriuretic peptide (nt-probnp), a pro-hormone secreted by the myocardium in response to various stimuli, was found to be correlated with several hemodynamic parameters in pulmonary hypertension associated with systemic sclerosis. |
| PubMedID- 20810505 | Prevalence of pulmonary hypertension in systemic sclerosis in european caucasians and metaanalysis of 5 studies. |
| PubMedID- 25332860 | Potential effect of sildenafil beyond pulmonary hypertension in a patient with diffuse systemic sclerosis and cryoglobulinemic vasculitis. |
| PubMedID- 21547892 | Objective: to develop a score to estimate the risk of developing pulmonary hypertension (ph) in patients with systemic sclerosis (ssc). |
| PubMedID- 21670950 | systemic sclerosis (ssc) is complicated by pulmonary hypertension and right ventricle (rv) failure in approximately 10% of the patients. |
| PubMedID- 22130821 | pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus. |
| PubMedID- 23910607 | pulmonary hypertension in systemic sclerosis: prevalence, incidence and predictive factors in a large multicentric italian cohort. |
| PubMedID- 26402988 | Pulmonary veno-occlusive disease: a rare cause of pulmonary hypertension in systemic sclerosis. |
Page: 1